FFP OR PRP IN ITP
Reading File
Finding Sources
Finding Sources
Searching PubMed
"immune thrombocytopenia" AND "platelet transfusion"
Finding Sources
Finding Sources
Reading File
Reading File
Here is a complete answer based on the textbook sources and current evidence:
FFP or PRP in ITP? - The Short Answer
Neither FFP nor PRP is indicated for ITP. Understanding why requires knowing the pathophysiology.
Why ITP is Different
ITP (Immune/Idiopathic Thrombocytopenic Purpura) is an autoimmune disease - the body produces autoantibodies (mainly IgG) directed against platelet surface antigens (GPIIb/IIIa, GPIb/IX). These antibody-coated platelets are then destroyed by macrophages in the spleen.
The problem is NOT a lack of platelets in the blood supply or a coagulation factor deficiency - it is accelerated immune-mediated platelet destruction.
Why FFP is NOT Useful in ITP
FFP (Fresh Frozen Plasma) contains:
- Clotting factors (I, II, V, VII, VIII, IX, X, XI)
- Von Willebrand factor
- Albumin and other plasma proteins
FFP is indicated for factor deficiencies (e.g., DIC, liver failure, warfarin overdose, TTP/HUS - where plasma exchange with FFP is the cornerstone). In ITP, clotting factors are normal. The PT, aPTT, and fibrinogen are all normal. Giving FFP adds nothing because the deficit is in platelet number, not in coagulation factors.
FFP is used in TTP (Thrombotic Thrombocytopenic Purpura - which is often confused with ITP). In TTP, plasma exchange with FFP replaces the deficient ADAMTS-13 enzyme. This is a key distinction.
Why Platelet Transfusion (PRP/Platelets) is Mostly Avoided in ITP
PRP (Platelet-Rich Plasma) / platelet concentrates are generally NOT useful in ITP because:
- The circulating anti-platelet antibodies will destroy transfused platelets just as fast as endogenous ones - often within minutes to hours
- Platelet transfusions provide only a transient and minimal rise in platelet count
- They do not address the underlying immune mechanism
Per the Sabiston Textbook of Surgery: "Platelet transfusion is indicated only for those who experience severe hemorrhage."
Per Rosen's Emergency Medicine: "Prophylactic platelet infusions should typically be reserved for [counts <10,000/mm³]."
So platelet transfusions are reserved for life-threatening emergencies (intracranial bleeding, massive GI hemorrhage) in ITP - given simultaneously with IVIG to briefly boost the count just long enough for hemostasis.
What IS the Correct Treatment for ITP?
| Line | Treatment | Mechanism |
|---|---|---|
| 1st line | Corticosteroids (Prednisone 1 mg/kg or Dexamethasone 40 mg x 4 days) | Reduce autoantibody production; decrease macrophage Fc receptor expression |
| 1st line (urgent) | IVIG (1 g/kg x 1-2 doses) | Saturates macrophage Fc receptors - blocks platelet destruction; fastest response |
| 1st line (Rh+ only) | Anti-D immunoglobulin (WinRho) | Coats RBCs, competing with platelets for macrophage destruction (not used post-splenectomy) |
| 2nd line | Rituximab (anti-CD20), Splenectomy | Reduce antibody-producing B cells; remove site of platelet destruction |
| 2nd line | TPO-RA: Romiplostim, Eltrombopag, Avatrombopag | Stimulate platelet production to outpace destruction |
| 3rd line | Fostamatinib (Syk inhibitor) | Blocks macrophage platelet phagocytosis |
| Emergency only | Platelet transfusion + IVIG | Temporarily boost platelet count before surgery/procedure |
- Washington Manual of Medical Therapeutics
- Rosen's Emergency Medicine, p. 5026-5034
Key Differentials (Where FFP DOES Matter)
| Condition | Platelet Count | FFP Role |
|---|---|---|
| ITP | Low | NO role |
| TTP | Low | YES - plasma exchange with FFP |
| DIC | Low + coagulopathy | YES - FFP + platelets |
| HUS | Low | Supportive; limited FFP role |
| Massive transfusion/dilutional | Low | YES - 1:1:1 ratio |
Summary
- FFP in ITP: No role. Clotting factors are normal in ITP. FFP does not address platelet destruction.
- PRP/Platelets in ITP: Not routine. Transfused platelets are rapidly destroyed by the same antibodies. Reserved only for life-threatening bleeding as a bridge measure alongside IVIG.
- The real treatment: Immunomodulation (steroids, IVIG) to stop antibody-mediated platelet destruction, not replacement of blood components.
A 2025 systematic review on treatment of critical bleeds in ITP (PMID 39552264, Eur J Haematol) further supports that management of severe/critical bleeding in ITP focuses on combination immunotherapy escalation rather than simple blood product replacement.
This is a shared conversation. Sign in to Orris to start your own chat.